Relatieve apicale sparing op strain-echo voor cardiale amyloïdose: meta-analyse van 41 studies
Cardiale amyloïdose (CA) wordt vaak gemist door aspecifieke klinische en echografische kenmerken. Deze systematische review en meta-analyse (41 studies, 3.473 CA-patiënten en 4.525 controles) onderzocht de diagnostische waarde van het patroon van relatieve apicale sparing (RELAPS) bij speckle-tracking-echocardiografie — de apicale longitudinale strain gedeeld door de som van de basale en mid-ventriculaire strain. De gepoolde AUC was 0,82, met een sensitiviteit van 66% en een specificiteit van 83%. Voor het AL-subtype was de specificiteit het hoogst (93%) en voor ATTR 84%, zonder significant verschil tussen subtypen. De prestaties verschilden wel duidelijk per analysesoftware (GE EchoPAC en Philips QLAB beter dan TomTec). RELAPS biedt dus een redelijke diagnostische nauwkeurigheid met goede specificiteit maar matige sensitiviteit — bruikbaar als rode vlag, mits gestandaardiseerde meting en vooraf vastgelegde afkapwaarden worden gebruikt.
Abstract (original)
<sec><st>Background</st> <p>Cardiac amyloidosis (CA) is underdiagnosed due to non-specific clinical and echocardiographic features. This systematic review and meta-analysis evaluated the diagnostic accuracy of the left ventricular relative apical sparing (RELAPS) pattern on speckle-tracking echocardiography.</p> </sec> <sec><st>Methods</st> <p>A literature search of PubMed, Scopus and Cochrane was conducted through August 2025. RELAPS was defined as the average apical longitudinal strain divided by the sum of average basal and average middle left ventricular longitudinal strains. Diagnostic accuracy was assessed using a bivariate random-effects model. Subgroup analyses by CA subtype and echocardiogram software, and meta-regression for clinical variables, were performed. Optimal cut-offs were determined by maximising the Youden index. Analyses were conducted in R V.4.4.1.</p> </sec> <sec><st>Results</st> <p>Forty-one studies (3473 CA; 4525 comparators) were included. Pooled analysis yielded an area under the receiver operating characteristic curve (AUC-ROC) of 0.818, with sensitivity 65.9% (95% CIs 59.2% to 72.0%) and specificity 83.1% (CI 78.5% to 86.8%). The diagnostic oods ratio (DOR) was 9.54 (CI 7.41 to 12.10). In subtype analyses, immunoglobulin light chains (AL-CA) showed AUC-ROC 0.876, sensitivity 59.8% (CI 41.1% to 76.0%) and specificity 92.7% (CI 83.6% to 96.9%); transthyretin (ATTR-CA) showed AUC-ROC 0.822, sensitivity 63.8% (CI 51.2% to 74.8%) and specificity 84.4% (CI 76.7% to 89.9%), with no significant differences between subtypes (sensitivity p=0.760; specificity p=0.172). Three echocardiography software systems were evaluated. GE EchoPAC (26 studies) achieved an AUC-ROC of 0.822 (sensitivity 70.4% (CI 64.1% to 76.0%), specificity 81.2% (CI 75.7% to 85.7%)). Philips QLAB (four studies) performed comparably (AUC-ROC 0.904; sensitivity 67.6% (CI 31.2% to 90.6%), specificity 92.7% (CI 73.6% to 98.3%)). In contrast, TomTec (four studies) had an AUC-ROC of 0.806, but its sensitivity (31.1% (CI 9.4% to 66.3%)) was significantly lower than GE EchoPAC’s (p<0.001), despite a similar specificity (93.6% (CI 78.8% to 98.3%)).</p> </sec> <sec><st>Conclusion</st> <p>RELAPS provides moderate diagnostic accuracy for identifying CA, with good specificity and modest sensitivity. Performance varies by analysis software and threshold, underscoring the need for standardised measurement and prespecified cut-offs.</p> </sec>
Dit artikel is een samenvatting van een publicatie in Open Heart. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.
Lees het volledige artikelLid worden van HartVaat.nl?
Gratis — en we stemmen het nieuws en de literatuur af op uw vakgebied.